4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 27 August 2021

⏱️ 59 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON. Feasibility of RCTs: doi.org/10.1093/jncics/pkab061 RR of Alternative Treatments: doi.org/10.1002/ijc.33231 Study Time Reduction: doi.org/10.1001/jamainternmed.2018.8351 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.9	I'm Vinay Prasad. I'm an associate professor with University of California, San Francisco.
0:11.9	I'm a practicing he-mong doctor, and my interests are medicine, oncology, and health policy.
0:16.4	And that's what you're going to get on Plenary Session.
0:21.6	This is season four, hashtag zero COVID.
0:24.6	It's zero COVID because we're not going to talk about COVID.
0:26.6	We're back, oncology, medicine, health policy.
0:29.6	We've got a lot in store for you.
0:33.6	But first, a plug.
0:34.6	If you like this podcast, leave us a rating or write us a review. It helps new listeners find the show. You can follow us on Twitter at Plenary underscore Session. You can email us at plenary session podcast at gmail.com. Give us your suggestions on what we should be covering. And we got a new YouTube channel, Vinay Prasad, MDMPH. Follow us on YouTube. I'm putting up a 10-part series on reading and interpreting cancer clinical trials.
0:57.6	You'll want to watch it there.
1:00.3	And if you really love this show, you can back us on patreon.com.
1:04.1	Patreon backers get access to slides for lectures I give on plenary session.
1:08.3	And with that, let's start the show.
1:16.1	I'm joined by Dr. Saroje Naraula. He's an associate professor of medicine at the University of Manitoba, Winnipeg, Canada. He's talking about a new paper looking at whether or not we
1:20.0	can do randomized control trials for all of these cancer drugs we approve on the basis of single
1:24.3	arm uncontrolled data. Below, I'm going to put links to three papers we talk about.
1:30.3	And, well, this paper is good, but unfortunately, in the course of our dialogue, we had
1:34.3	one internet hiccup.
1:36.3	The internet went away for a while.
1:37.3	I've done my best to mend it, but please forgive me.
1:40.3	So, with that, I introduce Seroz Norella.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.